Author

Timo Minssen

Timo Minssen is Professor of Law at the University of Copenhagen (UCPH) and the Founder and Managing Director of UCPH’s Center for Advanced Studies in Biomedical Innovation Law (CeBIL). He is also affiliated with Lund University as a researcher in Quantum Law. His research concentrates on Intellectual Property, Competition & Regulatory Law with a special focus on new technologies in the pharma, life science & biotech sectors including biologics and biosimilars. His studies comprise a plethora of legal issues emerging in the lifecycle of biotechnological and medical products and processes – from the regulation of research and incentives for innovation to technology transfer and commercialization.
  • Biotechnology

    Two new publications on “European patent strategies under the UPCA” and on “Synthetic Biology & Intellectual Property Rights”

    By Timo Minssen I am pleased to announce two new publications on (1) “European patent strategies under the UPCA” and (2)  “Synthetic Biology & Intellectual Property Rights”: 1) Minssen, T & Lundqvist, B 2014, ‘The…

    Two new publications on “European patent strategies under the UPCA” and on “Synthetic Biology & Intellectual Property Rights”

    By

    Timo Minssen

  • Biotechnology

    European Responses to the Ebola Crisis: Initiatives at the European Medicines Agency (EMA)

    By Timo Minssen The current Ebola outbreak already attracted much attention on “Bill of Health” resulting in some excellent blogs on a horrible topic. While it is evident that the current health crisis requires both immediate…

    European Responses to the Ebola Crisis: Initiatives at the European Medicines Agency (EMA)

    By

    Timo Minssen

  • Bioethics

    Call for Proposals: The 2016 Brocher Foundation Residencies

    By Timo Minssen I have just been informed that a new call for proposals for the 2016 Brocher Foundation residencies has been launched. I can warmly recommend this splendid opportunity to any researcher or group of researchers in the fields of Bioethics, Medical…

    Call for Proposals: The 2016 Brocher Foundation Residencies

    By

    Timo Minssen

  • Biotechnology

    The Fight Against Antimicrobial Resistance: Important recent publications

    By Timo Minssen One of my previous blogs discussed the growing threat of antimicrobial resistance (AMR). I concluded that antimicrobial resistance is a growing and complex threat involving multifaceted legal, socio-economic and scientific aspects. This…

    The Fight Against Antimicrobial Resistance: Important recent publications

    By

    Timo Minssen

  • Biotechnology

    Summer Course for Professionals in “Pharma Law & Policy” at the University of Copenhagen

    Stay abreast with recent developments and trends determining the legal and regulatory framework of the European pharmaceutical industry. What are the most significant current issues shaking and shaping the pharmaceutical industry today? The business environment…

    Summer Course for Professionals in “Pharma Law & Policy” at the University of Copenhagen

    By

    Timo Minssen

  • Petrie-Flom Center

    Thank you and farewell

    By Timo Minssen I have now left Harvard Law School and returned to Europe and commenced my work with IPRs and “biobanking” as a visiting research fellow at the University of Oxford. I remember the…

    Thank you and farewell

    By

    Timo Minssen

  • Bioethics

    A More Transparent System for Clinical Trials Data in Europe – Mind the Gaps!

    By Timo Minssen Following the approval of the European Parliament (EP) earlier last month, the Council of the European Union (the Council) adopted on 14 April 2014 a “Regulation on clinical trials on medicinal products…

    A More Transparent System for Clinical Trials Data in Europe – Mind the Gaps!

    By

    Timo Minssen

  • Biotechnology

    Review of Minssen, “Assessing the Inventiveness of Biopharmaceuticals under the European and U.S. Patent Laws”

    In “The “Problem” with the European Problem/Solution Approach to Inventive Step,” Harold C. Wegner reviews Petrie-Flom Visiting Scholar Timo Minssen‘s doctoral thesis. From the review: Patent applicants seeking to gain global patent protection beyond their…

    Review of Minssen, “Assessing the Inventiveness of Biopharmaceuticals under the European and U.S. Patent Laws”

    By

    Timo Minssen